Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Open Orphan Plc ( (GB:HVO) ) is now available.
JPMorgan Asset Management Holdings Inc. has reduced its voting rights in hVIVO PLC to below the minimum threshold, as notified on January 30, 2025. This change in holding could signal a strategic shift in JPMorgan’s investment approach, potentially impacting hVIVO’s shareholder composition and market perception.
More about Open Orphan Plc
hVIVO PLC operates within the biotechnology industry, focusing on clinical trial services and research related to infectious and respiratory diseases. The company’s primary services include the development and testing of vaccines and antivirals, serving pharmaceutical companies and healthcare organizations globally.
YTD Price Performance: -7.32%
Average Trading Volume: 3,849,464
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £129.3M
See more insights into HVO stock on TipRanks’ Stock Analysis page.
